Loading clinical trials...

Evaluating Benefit of Peptide Based Diet in Obese HEN Patients | Clinical Trials | Clareo Health

ENROLLING_BY_INVITATIONNA

Evaluating Benefit of Peptide Based Diet in Obese HEN Patients

Effect of Hypocaloric, High-protein Enteral Formula on Body Weight and Health Outcomes in Obese HEN Patients: A Pilot Study

NCT05080699•Mayo Clinic

View on ClinicalTrials.gov

Summary

The purpose of this study is to assess the effects of a low energy, high protein tube feeding formula on body weight in tube fed patients who are obese. It will also assess study formula tolerance as well as impact of the study formula on lean body mass, blood pressure, blood sugar and lipids.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Home Enteral Nutrition (HEN) patient receiving at least 90% of energy needs from enteral nutrition.
•BMI \> 30.
•History of stroke.
•Weight stable over the past month.

Exclusion Criteria

•Diagnosis of cancer undergoing active treatment (chemotherapy, radiation, immunotherapy).
•Life expectancy of less than 6 months.
•Stage IV or higher kidney disease (GFR \< 30).

Locations (1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

Key Dates

Start Date

March 25, 2023

Primary Completion Date

December 1, 2027

Completion Date

December 1, 2027

Last Updated

January 26, 2026

Enrollment

ESTIMATED participants

Conditions

Obesity

Interventions

Peptamen Intense VHP, Nestlé Health Science, Switzerland

DIETARY_SUPPLEMENT

Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

NCT01143454

Metabolic DiseaseObesity+4 more

View study

RECRUITINGNA

Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women

NCT07472881

MenopausePerimenopause+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 26, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Evaluating Benefit of Peptide Based Diet in Obese HEN Patients

Inclusion Criteria

Exclusion Criteria

Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women

Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial

Protein Supplementation Intervention on Body Weight

Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose

iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss